Parenteral Nutrition Market (Type of Nutrition - Carbohydrates, Parenteral Lipid Emulsions, Single Dose Amino Acid Solutions, Trace Elements, Electrolytes and Minerals, Vitamins) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2030

Description

The global parenteral nutrition market for the historical period 2017–2018 and forecast period 2019–2027, rising incidence of chronic diseases and growing approvals to novel parenteral nutrition components are projected to drive the global parenteral nutrition market during the forecast period

According to the report, the global parenteral nutrition market was valued at US$ 5.6 Bn in 2018 and is anticipated to grow at a CAGR of 4.6% from 2019 to 2027

High Incidence and prevalence of chronic diseases across the globe: Key Driver

High prevalence and rise in incidence rate of chronic diseases across the globe is a key factor driving the global parenteral nutrition market.

The rise in cancer, AIDS, diabetes, Crohn’s disease, gastro-intestinal disorders, and short bowel syndrome cases has also fuelled the consumption of parenteral nutrition in recent years

For instance, according the National Kidney Foundation stated around 10% of the world’s population is affected by chronic kidney disease each year.

Furthermore, rise in cases of malnutrition among the geriatric population is fuelling the growth of global parenteral nutrition market.

For instance, as per the National Resource Center on Nutrition, Physical Activity & Aging, around 1 million housebound older people are malnourished every year in North America

Moreover increase in approvals of novel parenteral components and rise in research & development activities by major companies for new product development are some of the major factors responsible for the growth of global parenteral nutrition market.

Get a glimpse of the in-depth analysis through our Report Brochure

Side effects and complications related to parenteral nutrition products hamper the market growth

Inappropriate usage of parenteral nutrition maximizes the potential risk of adverse events such as refeeding syndrome, particulate contamination, catheter infections, and liver dysfunction to the patients undergoing the therapy. This factor can restrain the market growth.

For instance, an article published by the American Society for Nutrition in 2014 indicated that long-term parenteral nutrition therapy significantly increases the risk of liver disease and metabolic complications in patients.  

Global parenteral nutrition Market: North America dominated the global market

On the basis of region, the parenteral nutrition market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

North America region dominated the global market owing to higher prevalence of chronic diseases such as cancer, diabetes in the region, growing approval of U.S. FDA approved parenteral nutrition products in recent years, and higher R&D investment funding by major companies.

However, Asia-Pacific region is considered as the most lucrative market during the forecast period from 2019 to 2027. The growth is mainly ascribed to factors such as growing aging population which is more prone to chronic diseases, growing awareness of parenteral nutrition, and improving healthcare infrastructure in the region.

Global Parenteral nutrition Market: Competitive Landscape

This report profiles major players in the global parenteral nutrition market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

The global parenteral nutrition market is highly consolidated, with a few global players accounting for a major share in market.

Leading players operating in the global Parenteral nutrition market are

  • Allergan plc.
  • Pfizer Inc.
  • B.Braun Melsungen AG
  • Fresenius Kabi AG
  • Grifols, S.A.
  • Baxter International, Inc.
  • Vifor Pharma Management Ltd.
  • Sichuan Kelun Pharmaceutical Co., Ltd., 

Key Questions Answered in Global Parenteral Nutrition market Report

  • What is the scope of growth of product companies in the global parenteral nutrition market?
  • What will be the Y-o-Y growth of the global parenteral nutrition market between 2019 and 2027?
  • What is the influence of changing trends in pipeline products on the global parenteral nutrition market?
  • Will North America continue to be the most profitable market for parenteral nutrition providers?
  • Which factors are anticipated to hamper the growth of the global parenteral nutrition market during the forecast period?
  • Which are the leading companies in the global parenteral nutrition market?

Global Parenteral Nutrition market – Segmentation

Type

  • Carbohydrates
  • Parenteral Lipid Emulsions
  • Single Dose Amino Acid Solutions
  • Trace Elements, Electrolytes & Minerals
  • Vitamins

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Parenteral Nutrition Market

4. Market Overview

        4.1. Introduction

            4.1.1. By Type  Introduction

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Parenteral Nutrition Market Analysis and Forecasts, 2017–2027

            4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

        5.1. Clinical Trial Pipeline Analysis

        5.2. Key Mergers & Acquisitions

        5.3. Cancer Diseases Epidemiology Analysis, by Key Country/Region

        5.4. Inflammatory Bowel Diseases Epidemiology Analysis, by Key Country/Region

        5.5. Preterm Birth Epidemiology Analysis, by Key Country/Region

6. Global Parenteral Nutrition Market Analysis and Forecast, by Type  

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Global Parenteral Nutrition Market Value Forecast, by Type, 2017–2027

            6.3.1. Carbohydrates

            6.3.2. Parenteral Lipid Emulsions

            6.3.3. Single Dose Amino Acid Solutions 

            6.3.4. Trace Elements, Electrolytes, & Minerals

            6.3.5. Vitamins

        6.4. Global Parenteral Nutrition Market Attractiveness, by Type, 2019-2027  

7. Global Parenteral Nutrition Market Analysis and Forecast, by Region

        7.1. Key Findings

        7.2. Global Parenteral Nutrition Market Value Forecast, by Region

            7.2.1. North America 

            7.2.2. Europe 

            7.2.3. Asia Pacific 

            7.2.4. Latin America 

            7.2.5. Middle East & Africa 

        7.3. Global Parenteral Nutrition Market Attractiveness, by Region, 2019-2027

8. North America Parenteral Nutrition Market Analysis and Forecast

        8.1. Introduction

            8.1.1. Key Findings

        8.2. North America Parenteral Nutrition Market Value Forecast, by Type, 2017–2027

            8.2.1. Carbohydrates

            8.2.2. Parenteral Lipid Emulsions

            8.2.3. Single Dose Amino Acid Solutions 

            8.2.4. Trace Elements, Electrolytes, & Minerals

            8.2.5. Vitamins

        8.3. North America Parenteral Nutrition Market Value Forecast, by Country, 2017–2027

            8.3.1. U.S.

            8.3.2. Canada

        8.4. North America Parenteral Nutrition Market Attractiveness Analysis, 2019-2027 

            8.4.1. By Type  

            8.4.2. By Country

9. Europe Parenteral Nutrition Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. Europe Parenteral Nutrition Market Value Forecast, by Type, 2017–2027

            9.2.1. Carbohydrates

            9.2.2. Parenteral Lipid Emulsions

            9.2.3. Single Dose Amino Acid Solutions 

            9.2.4. Trace Elements, Electrolytes, & Minerals

            9.2.5. Vitamins

        9.3. Europe Parenteral Nutrition Market Value Forecast, by Country/Sub-region, 2017–2027

            9.3.1. Germany

            9.3.2. U.K.

            9.3.3. France

            9.3.4. Spain

            9.3.5. Italy

            9.3.6. Rest of Europe

        9.4. Europe Parenteral Nutrition Market Attractiveness Analysis, 2019-2027

            9.4.1. By Type  

            9.4.2. By Country/Sub-region

10. Asia Pacific Parenteral Nutrition Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Asia Pacific Parenteral Nutrition Market Value Forecast, by Type, 2017–2027

            10.2.1. Carbohydrates

            10.2.2. Parenteral Lipid Emulsions

            10.2.3. Single Dose Amino Acid Solutions 

            10.2.4. Trace Elements, Electrolytes, & Minerals

            10.2.5. Vitamins

        10.3. Asia Pacific Parenteral Nutrition Market Value Forecast, by Country/Sub-region, 2017–2027

            10.3.1. China

            10.3.2. Japan

            10.3.3. India

            10.3.4. Australia & New Zealand

            10.3.5. Rest of Asia Pacific

        10.4. Asia Pacific Parenteral Nutrition Market Attractiveness Analysis, 2019-2027

            10.4.1. By Type  

            10.4.2. By Country/Sub-region

11. Latin America Parenteral Nutrition Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Latin America Parenteral Nutrition Market Value Forecast, by Type, 2017–2027

            11.2.1. Carbohydrates

            11.2.2. Parenteral Lipid Emulsions

            11.2.3. Single Dose Amino Acid Solutions 

            11.2.4. Trace Elements, Electrolytes, & Minerals

            11.2.5. Vitamins

        11.3. Latin America Parenteral Nutrition Market Value Forecast, by Country/Sub-region, 2017–2027

            11.3.1. Brazil

            11.3.2. Mexico

            11.3.3. Rest of Latin America

        11.4. Latin America Parenteral Nutrition Market Attractiveness Analysis, 2019-2027

            11.4.1. By Type  

            11.4.2. By Country/Sub-region

12. Middle East & Africa Parenteral Nutrition Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Middle East & Africa Parenteral Nutrition Market Value Forecast, by Type, 2017–2027

            12.2.1. Carbohydrates

            12.2.2. Parenteral Lipid Emulsions

            12.2.3. Single Dose Amino Acid Solutions 

            12.2.4. Trace Elements, Electrolytes, & Minerals

            12.2.5. Vitamins

        12.3. Middle East & Africa Parenteral Nutrition Market Value Forecast, by Country/Sub-region, 2017–2027

            12.3.1. GCC Countries

            12.3.2. South Africa

            12.3.3. Rest of Middle East & Africa

        12.4. Middle East & Africa Parenteral Nutrition Market Attractiveness Analysis, 2019-2027

            12.4.1. By Type  

            12.4.2. By Country/Sub-region

13. Competition Landscape

        13.1. Global Parenteral Nutrition Market Player – Competition Matrix (By Tier and Size of companies)

        13.2. Global Parenteral Nutrition Market Share/Position Analysis, by Company (2018)

        13.3. Company Profiles

            13.3.1. Allergan plc.

                     13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                     13.3.1.2. Company Financials

                     13.3.1.3. Growth Strategies

                     13.3.1.4. SWOT Analysis

            13.3.2. Pfizer Inc.

                     13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                     13.3.2.2. Company Financials

                     13.3.2.3. Growth Strategies

                     13.3.2.4. SWOT Analysis

            13.3.3. B.Braun Melsungen AG

                     13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                     13.3.3.2. Company Financials

                     13.3.3.3. Growth Strategies

                     13.3.3.4. SWOT Analysis

            13.3.4. Fresenius Kabi AG

                     13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                     13.3.4.2. Company Financials

                     13.3.4.3. Growth Strategies

                     13.3.4.4. SWOT Analysis

            13.3.5. Grifols, S.A.

                     13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                     13.3.5.2. Company Financials

                     13.3.5.3. Growth Strategies

                     13.3.5.4. SWOT Analysis

            13.3.6. Baxter International, Inc.

                     13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                     13.3.6.2. Company Financials

                     13.3.6.3. Growth Strategies

                     13.3.6.4. SWOT Analysis

            13.3.7. Vifor Pharma Management Ltd.

                     13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                     13.3.7.2. Company Financials

                     13.3.7.3. Growth Strategies

                     13.3.7.4. SWOT Analysis

            13.3.8. Sichuan Kelun Pharmaceutical Co., Ltd.,

                     13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                     13.3.8.2. Growth Strategies

                     13.3.8.3. SWOT Analysis

Choose License Type

Checkout Inquiry Sample